Market news — every asset we track

Assets

ESPR

Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), Alnylam Pharma (ALNY) and Esperion (ESPR)

Detailed price information for Alnylam Pharmaceuticals (ALNY-Q) from The Globe and Mail including charting and trades.

Jul 15The Globe and Mail

Esperion acquired in cash-and-CVR merger transaction

Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.

Jul 14The Globe and Mail

ESPR

Esperion Therapeutics Clears Key Hurdle as Stockholders Approve Essence Merger

Stockholders of Esperion Therapeutics (NASDAQ:ESPR) approved the company’s merger agreement with Essence Parent and Essence MergerCo at a special meeting held virtually on July 8, 2026, according to remarks delivered during the meeting. J. Martin Carroll, chairperson of Esperion’s board of director

Jul 10Yahoo Finance

ESPR

Esperion shareholders approve merger with Essence Parent Inc.

Detailed price information for Esperion Theraptc (ESPR-Q) from The Globe and Mail including charting and trades.

Jul 9The Globe and Mail

ESPR

This is the newest page. Registered accounts read further back.